Ten Bio News
It’s just the start of Ten Bio’s journey…
A note from the Chair. I was introduced to Ten Bio’s founders in November 2019. I was immediately engaged by two things: firstly, the logic
Exploring UVC light for virus control
Ten Bio is contributing to a collaborative research project led by the University of St Andrews, funded by Innovate UK, to investigate the use of UVC light in inactivating airborne viruses.
Investment enables Ten Bio to establish new skin testing technology in USA
A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide
TenSkin used to show effects of filtered far-UVC radiation in skin
Ten Bio’s innovative human skin model, TenSkinTM, features in a recent publication assessing the carcinogenic risk through direct DNA damage of filtered far-UVC exposure. This
Ten Bio win at Scottish Edge
Ten Bio Ltd has won £65,000 in a national competition supporting Scotland’s most exciting new enterprises. Scottish EDGE is the UK’s largest business funding competition,
Converge Challenge prize for Ten Bio
Dr Hickerson was last night named runner-up in the Converge Challenge category of Converge 2020, receiving £29,000 in cash and in-kind business support. Converge is
Ten Bio launched from University of Dundee
Ten Bio launched from University of Dundee Researchers from the University of Dundee are looking to transform pharmaceutical and cosmetics testing with their spinout venture
Wounding response and wound healing in a novel tension-based skin explant model
This study highlights a tensioned ex vivo skin model that maintains viability and replicates in vivo wound healing. Improved keratin expression and 3D visualization confirm its value for studying biomarkers and testing therapies.
A tension-based skin explant model
This study introduces a tensioned ex vivo skin model that maintains viability, structural integrity, and physiological complexity. Unlike traditional models, it replicates in vivo responses, supports toxicity studies, and shows promise for dermatology research and drug discovery, reducing reliance on animal testing.
Microneedle testing: why skin tension matters for human-relevant data
Microneedle technologies are advancing rapidly, but accurately assessing their performance depends on how closely test systems reflect real human skin. Preserving physiological tension is a key factor in generating reliable, human-relevant data.
The future of wearable technologies in skin research
Wearable technologies are evolving into platforms that generate continuous insight into skin health and underlying physiology. As devices become more biologically integrated, skin is emerging as a critical interface — shaping what wearables can measure and how reliably they perform. This article explores where skin-interfacing wearables are heading and how TenSkin™ helps bridge early development and real-world use.
Understanding eczema: Beyond symptoms
Eczema (atopic dermatitis) affects millions worldwide, yet many of its underlying mechanisms are still being uncovered. In this article, Professor Alan Irvine outlines what science understands about the condition’s causes — from the role of the skin barrier and immune pathways to the influence of the microbiome and environment — and explains how these insights are shaping innovative approaches to prevention and treatment.
Bridging the gap: Comparing topical drug absorption and activity in mouse and human skin models
Mouse models remain a cornerstone of dermatology research, but their differences from human skin — in follicle density, barrier function, and wound healing — can limit translation. This article explores the critical factors that shape absorption and pharmacological activity, and considers how human-based models can improve predictive power.
Why psoriasis research needs a human-relevant approach — and how ex vivo models can deliver
Explore how TenSkin™, Ten Bio’s ex vivo human skin model, is helping researchers study psoriasis with greater accuracy and human relevance — reducing reliance on animal testing and improving translational outcomes.
A season of global engagement in skin science and innovation
This spring, Ten Bio joined leading voices in dermatology at events in France, the US, and Australia—spotlighting TenSkin™ as a powerful, human-relevant alternative to animal testing. From photoprotection to microneedle delivery, the message was clear: innovation needs better models.